Arcturus Therapeutics Holdings
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Arcturus Therapeutics Holdings's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 23% to $157,748,000. Profit margin reached -19%. Total operating expenses were $235,953,000.

Profit Margin

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT): Profit margin
2014 0 -32.83M
2015 6.13M -19.44M -316.86%
2016 0 -24.60M
2017 12.99M -10.90M -83.87%
2018 15.75M -21.78M -138.29%
2019 20.78M -25.72M -123.72%
2020 9.53M -71.36M -748.13%
2021 12.35M -206.86M -1673.78%
2022 205.75M 9.34M 4.54%
2023 157.74M -29.72M -18.84%

ARCT Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
157.74M205.75M12.35M9.53M20.78M15.75M12.99M06.13M0
Cost of revenue
2.95M143.05M171.86M55.94M32.43M0410K051K0
Gross profit
154.79M62.70M-159.50M-46.40M-11.65M15.75M12.58M06.08M0
Operating exp.
Research and development
192.13M147.75M173.76M57.84M33.64M16.98M15.91M18.39M13.46M25.10M
Selling and marketing
0000000000
Total operating expenses
235.95M193.57M215.21M81.06M46.30M37.56M23.49M25.16M19.69M33.07M
Operating income
-78.20M12.17M-202.85M-71.52M-25.51M-21.81M-10.49M-25.16M-19.69M-33.07M
Other income (expenses), net
50.31M-1.53M-822K-624K-478K-302K-409K-1.41M11K227K
Income before tax
-27.89M10.64M-203.67M-72.14M-25.99M-21.78M-10.90M-24.53M-19.39M-32.85M
Income tax expense
1.83M1.29M3.18M-784K-270K212K1K73K51K-17K
Net income
-29.72M9.34M-206.86M-71.36M-25.72M-21.78M-10.90M-24.60M-19.44M-32.83M
Earnings per share
Basic EPS
-1.120.35-7.86-3.51-2.13-2.16-3.53-6.25-6.29-16.81
Diluted EPS
-1.120.35-7.86-3.51-2.13-2.16-3.53-6.25-6.29-16.81
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source